Showing results (851-860 of 2,865) with videos related to
Sort By:
Pageof 287
JACC. Cardiovascular Interventions|September 26, 2009
Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complicationsJean-Bernard Masson, Jan Kovac, Gerhard Schuler, et al.JACC. Cardiovascular Interventions|September 26, 2009
Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trialChristopher Lichtenwalter, James A de Lemos, Michele Roesle, et al.JACC. Cardiovascular Interventions|September 26, 2009
Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudyJoanna J Wykrzykowska, Patrick W Serruys, Yoshinobu Onuma, et al.JACC. Cardiovascular Interventions|August 22, 2009
Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention eraDavid R Holmes, Rick Nishimura, Rebecca Fountain, et al.JACC. Cardiovascular Interventions|August 22, 2009
Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graftDavide Capodanno, Piera Capranzano, Maria Elena Di Salvo, et al.JACC. Cardiovascular Interventions|August 22, 2009
A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosisHursh Naik, Anthony J White, Tarun Chakravarty, et al.JACC. Cardiovascular Interventions|August 22, 2009
Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudyRoxana Mehran, Eugenia Nikolsky, Alexandra J Lansky, et al.JACC. Cardiovascular Interventions|August 22, 2009
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?Cheng-Hon Yap, Bryan P Yan, Enoch Akowuah, et al.JACC. Cardiovascular Interventions|August 22, 2009
In-hospital and 1-year outcomes among unselected percutaneous coronary intervention patients treated with either sirolimus- or paclitaxel-eluting stents: results from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registryVictor Novack, Donald Cutlip, Neal Kleiman, et al.JACC. Cardiovascular Interventions|August 22, 2009
A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial)S Chiu Wong, William Bachinsky, Patrick Cambier, et al.Pageof 287